⚡ Flash Summary

IBL Healthcare Limited held its 28th Annual General Meeting on October 28, 2025. Shareholders approved the minutes of the previous AGM held on October 28, 2024. The audited financial statements for the year ended June 30, 2025, along with the Director’s Reports, were adopted. A.F. Ferguson & Co. were re-appointed as auditors for the upcoming year, with their remuneration to be determined by the Directors.

📌 Key Takeaways

• ✅ Minutes of the previous AGM held on October 28, 2024, were approved.
• ✅ Audited financial statements for the year ended June 30, 2025, along with Director’s Reports, were adopted.
• ✅ A.F. Ferguson & Co. re-appointed as auditors for the next Annual General Meeting.
• 💰 Authorized share capital increased from Rs. 1,050,000,000 to Rs. 1,500,000,000.
• 📈 Creation of 45,000,000 additional ordinary shares at a nominal value of Rs. 10 each.
• 📜 Memorandum and Articles of Association altered to reflect the increased authorized share capital.
• 🧑‍💼 Company Secretary authorized to complete legal formalities for implementing the resolution.
• 🎁 Bonus shares issued at a ratio of 15 shares for every 100 shares held.
• 💸 A sum of Rs. 128,512,147 capitalized for issuing 12,851,214 ordinary bonus shares.
• 🗓️ Shareholders registered as of October 08, 2025, eligible for bonus shares.
• 🤝 Transactions with Related Parties as disclosed in Note 35 of the financial statements were ratified and approved.
• 🧑‍⚖️ Board of Directors authorized to approve Related Party transactions on a case-to-case basis until the next AGM.
• 📝 Transactions approved by the Board will be presented to shareholders for formal ratification at the next AGM.

🎯 Investment Thesis

HOLD. The increase in authorized share capital and issuance of bonus shares presents both opportunities and risks. Further analysis is needed to assess the long-term impact of these decisions on the company’s financial performance and valuation. Until more information is available, a HOLD recommendation is appropriate.